Abstract:Significance: Reactive oxygen species (ROS) are generated during mitochondrial oxidative metabolism, and are tightly controlled through homeostatic mechanisms to maintain intracellular redox, regulating growth and proliferation in healthy cells. However, ROS production is perturbed in cancers where abnormal accumulation of ROS leads to oxidative stress and genomic instability, triggering oncogenic signaling pathways on one hand, while increasing oxidative damage and triggering ROS-dependent death signaling on the other. Recent Advances: Our review illuminates how critical interactions between ROS and oncogenic signaling, the tumor microenvironment, and DNA damage response (DDR) pathways have led to interest in ROS modulation as a means of enhancing existing anticancer strategies and developing new therapeutic opportunities. Critical Issues: ROS equilibrium exists via a delicate balance of pro-oxidant and antioxidant species within cells. "Antioxidant" approaches have been explored mainly in the form of chemoprevention, but there is insufficient evidence to advocate its routine application. More progress has been made via the "pro-oxidant" approach of targeting cancer vulnerabilities and inducing oxidative stress. Various therapeutic modalities have employed this approach, including direct ROS-inducing agents, chemotherapy, targeted therapies, DDR therapies, radiotherapy, and immunotherapy. Finally, emerging delivery systems such as "nanosensitizers" as radiotherapy enhancers are currently in development. Future Directions: While approaches designed to induce ROS have shown considerable promise in selectively targeting cancer cells and dealing with resistance to conventional therapies, most are still in early phases of development and challenges remain. Further research should endeavor to refine treatment strategies, optimize drug combinations, and identify predictive biomarkers of ROS-based cancer therapies.

Oxidative cell death in cancer: mechanisms and therapeutic opportunities

Targeting Ferroptosis for Cancer Therapy: Exploring Novel Strategies from Its Mechanisms and Role in Cancers

Oxidative Stress in Cancer Immunotherapy: Molecular Mechanisms and Potential Applications

Targeted Therapy of Tumors and Cancer Stem Cells based on Oxidant-Regulated Redox Pathway and its Mechanism

Targeting ROS in cancer: rationale and strategies

The Role of Necroptosis in ROS-Mediated Cancer Therapies and Its Promising Applications

Reactive Oxygen Species Modulation in the Current Landscape of Anticancer Therapies

The Molecular Mechanisms of Regulating Oxidative Stress-Induced Ferroptosis and Therapeutic Strategy in Tumors

Redox Signaling: Potential Arbitrator of Autophagy and Apoptosis in Therapeutic Response

The Role of Oxidative Stress in Tumorigenesis and Progression

Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

Redox Regulation of Cell Survival

Controlling Cancer Cells Using Reactive Oxygen Species

Role of oxidative stress‐induced ferroptosis in cancer therapy

Advances in ferroptosis of cancer therapy

Cell death pathways: molecular mechanisms and therapeutic targets for cancer

Oxidative Stress in Cancer Therapy: Friend or Enemy?

ROS-induced lipid peroxidation modulates cell death outcome: mechanisms behind apoptosis, autophagy, and ferroptosis

The double-edged roles of ROS in cancer prevention and therapy

Non-apoptotic cell death-based cancer therapy: Molecular mechanism, pharmacological modulators, and nanomedicine

Dissecting the pleiotropic roles of reactive oxygen species (ROS) in lung cancer: From carcinogenesis toward therapy